Secondary Nephrogenic Diabetes Insipidus as a Complication of Inherited Renal Diseases

被引:45
作者
Bockenhauer, D.
van't Hoff, W.
Dattani, M.
Lehnhardt, A.
Subtirelu, M.
Hildebrandt, F.
Bichet, D. G.
机构
[1] Great Ormond Street Hospital for Children, London
[2] University Children's Hospital Hamburg, Hamburg
[3] UT College of Medicine Chattanooga, T.C. Thompson Children's Hospital, Chattanooga, TN
[4] Departments of Pediatrics, Human Genetics and Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI
[5] Departments of Medicine and Physiology, Université de Montréal, Hôpital du Sacré-Coeur de Montréal, Montréal, QC
来源
NEPHRON PHYSIOLOGY | 2010年 / 116卷 / 04期
关键词
SALT-LOSING TUBULOPATHIES; TUBULAR-ACIDOSIS; BARTTER-SYNDROME; NEPHRONOPHTHISIS; KIDNEY; CYSTINOSIS;
D O I
10.1159/000320117
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Nephrogenic diabetes insipidus (NDI) is a serious condition with large water losses in the urine and the risk of hypernatremic dehydration. Unrecognized, repeated episodes of hypernatremic dehydration can lead to permanent brain damage. Primary NDI is due to mutations in either AVPR2 or AQP2. NDI can also occur as a secondary complication, most commonly from obstructive uropathy or chronic lithium therapy. We observed NDI in patients with inherited tubulopathies and aimed to define the clinical and molecular phenotype. Methods: We reviewed the medical notes of 4 patients with clinical NDI and an underlying molecularly confirmed diagnosis of nephropathic cystinosis, Bartter syndrome, nephronophthisis and apparent mineralocorticoid excess, respectively. Results: The patients all failed to concentrate their urine after administration of 1-desamino[8-D-arginine] vasopressin. None had an identifiable mutation in AVPR2 or AQP2, consistent with secondary NDI. Patients experienced repeated episodes of hypernatremic dehydration, and in 2 cases, NDI was initially thought to be the primary diagnosis, delaying recognition of the underlying problem. Conclusion: The recognition of this potential complication is important as it has direct implications for clinical management. The occurrence of NDI in association with these conditions provides clues for the etiology of aquaporin deficiency. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:P23 / P29
页数:7
相关论文
共 30 条
[1]  
[Anonymous], COMPREHENSIVE PEDIAT
[2]  
AUGUST C, 1990, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V136, P367
[3]   Phenotypic variability in Bartter syndrome type I [J].
Bettinelli, A ;
Ciarmatori, S ;
Cesareo, L ;
Tedeschi, S ;
Ruffa, G ;
Appiani, AC ;
Rosini, A ;
Grumieri, G ;
Mercuri, B ;
Sacco, M ;
Leozappa, G ;
Binda, S ;
Cecconi, M ;
Navone, C ;
Curcio, C ;
Syren, ML ;
Casari, G .
PEDIATRIC NEPHROLOGY, 2000, 14 (10-11) :940-945
[4]  
Bichet DG, 1997, J AM SOC NEPHROL, V8, P1951
[5]   HEMODYNAMIC AND COAGULATION RESPONSES TO 1-DESAMINO[8-D-ARGININE] VASOPRESSIN IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS [J].
BICHET, DG ;
RAZI, M ;
LONERGAN, M ;
ARTHUS, MF ;
PAPUKNA, V ;
KORTAS, C ;
BARJON, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) :881-887
[6]  
BICHET DG, 1994, SEMIN NEPHROL, V14, P349
[7]   Antenatal Bartters syndrome: why is this not a lethal condition [J].
Bockenhauer, D. ;
Cruwys, M. ;
Kleta, R. ;
Halperin, L. F. ;
Wildgoose, P. ;
Souma, T. ;
Nukiwa, N. ;
Cheema-Dhadli, S. ;
Chong, C. K. ;
Kamel, K. S. ;
Davids, M. R. ;
Halperin, M. L. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2008, 101 (12) :927-942
[8]  
Bockenhauer D., 2008, Comprehensive Pediatric Nephrology, P489
[9]   Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus [J].
Bockenhauer, Detlef ;
Carpentier, Eric ;
Rochdi, Driss ;
van't Hoff, W. ;
Breton, Billy ;
Bernier, Virginie ;
Bouvier, Michel ;
Bichet, Daniel G. .
NEPHRON PHYSIOLOGY, 2010, 114 (01) :1-10
[10]   PREVALENCE, PATHOGENESIS, AND TREATMENT OF RENAL DYSFUNCTION ASSOCIATED WITH CHRONIC LITHIUM-THERAPY [J].
BOTON, R ;
GAVIRIA, M ;
BATLLE, DC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (05) :329-345